MedPath

A comparison of pain relief: using ropivacaine alone versus ropivacaine with dexmedetomidine in patients undergoing gallbladder removal through keyhole surgery.

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/07/071224
Lead Sponsor
Dr Amitha Anna Sajji
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)ASA Grade I and II Patients

2)Age group of 18-60 years

3)Those patients scheduled for laparoscopic cholecystectomy under general anaesthesia

Exclusion Criteria

1) ASA grade III and IV patients

2) History of allergy to study drugs.

3) cardiac pulmonary hepatic or renal disorders

4) Patient refusal

5) Morbid obese patients

6) Pregnant and lactating females

7) Baseline heart rate less than 50

8)Patients needing conversion to open cholecystectomy will be excluded

from the final analysis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the intensity of postoperative pain by visual analogue scale in the first 24 <br/ ><br>hours following intraperitoneal instillation of ropivacaine alone versus ropivacaine plus <br/ ><br>dexmedetomidine after laparoscopic cholecystectomy.Timepoint: Oh,2h,4h,6h,12h and 24 hour
Secondary Outcome Measures
NameTimeMethod
T0 compare the total dose of analgesic used in the first 24 hours between the two groups.Timepoint: 24 hours;To assess the occurrence of any adverse side effects between the two groups.Timepoint: 24 hours;To compare the time to first rescue analgesia between the two groups.Timepoint: 24 hours
© Copyright 2025. All Rights Reserved by MedPath